Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Emerald Bioscience Inc (EMBI)

Emerald Bioscience Inc (EMBI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 6,394
  • Shares Outstanding, K 142,095
  • Annual Sales, $ 0 K
  • Annual Income, $ 1,050 K
  • 60-Month Beta 0.63
  • Price/Sales N/A
  • Price/Cash Flow 0.54
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.05
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/14/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0410 +21.95%
on 08/07/20
0.1750 -71.43%
on 07/15/20
-0.0835 (-62.55%)
since 07/10/20
3-Month
0.0410 +21.95%
on 08/07/20
0.1949 -74.35%
on 06/29/20
-0.0300 (-37.50%)
since 05/11/20
52-Week
0.0410 +21.95%
on 08/07/20
0.4900 -89.80%
on 10/07/19
-0.2200 (-81.48%)
since 08/09/19

Most Recent Stories

More News
Emerald Bioscience Appoints Biotech Executive Punit Dhillon as CEO

Renewed team and capital focused on advancing lead compound for glaucoma into clinical development

EMBI : 0.0500 (+11.11%)
Emerald Bioscience Raises approximately $7.0 Million in Upsized Registered Offering

Emerald Bioscience, Inc. (OTCQB: EMBI) ("Emerald"), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to address global medical indications, today announced that it has...

EMBI : 0.0500 (+11.11%)
Emerald Bioscience Announces Pricing of $7.0 Million Upsized Registered Offering

Emerald Bioscience, Inc. (OTCQB: EMBI) ("Emerald"), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to address global medical indications, today announced that it has...

EMBI : 0.0500 (+11.11%)
Emerald Bioscience Announces Awarding of Patent for Cannabidiol-Valine-Hemisuccinate in Japan

Emerald Bioscience, Inc. (OTCQB: EMBI), focused on the development of cannabinoid-based therapeutics to address global medical indications, especially those of unmet medical need, today announced that...

EMBI : 0.0500 (+11.11%)
Chemotherapy Induced Nausea And Vomiting Market Therapeutic Survey Reviews, Analysis 2030 | Acacia Pharma Ltd, Aphios Corp, Astellas Pharma Inc

(MENAFN - Ameliorate Solutions) Chemotherapy Induced Nausea And Vomiting Market Report provides the detailed overview of the disease and in depth understanding of historical and forecasted epidemiology....

ALPMF : 15.1200 (-4.03%)
IGX.VN : 0.260 (-13.33%)
IGXT : 0.1910 (-7.77%)
ALPMY : 16.0950 (+2.99%)
ATNX : 11.70 (+0.60%)
MNKD : 1.6000 (+0.63%)
MDC : 42.50 (-3.67%)
EMBI : 0.0500 (+11.11%)
Chemotherapy Induced Nausea And Vomiting Market Therapeutic Survey Reviews, Analysis 2030 | Acacia Pharma Ltd, Aphios Corp, Astellas Pharma Inc

Chemotherapy Induced Nausea And Vomiting Market Report provides the detailed overview of the disease and in depth understanding of historical and forecasted epidemiology. It highlights the existing treatment...

ALPMF : 15.1200 (-4.03%)
IGX.VN : 0.260 (-13.33%)
IGXT : 0.1910 (-7.77%)
ALPMY : 16.0950 (+2.99%)
ATNX : 11.70 (+0.60%)
MNKD : 1.6000 (+0.63%)
MDC : 42.50 (-3.67%)
EMBI : 0.0500 (+11.11%)
Emerald Bioscience Joins Alliance for Biosecurity

The Alliance is a government-industry consortium that is a leading voice on biosecurity issues in the United States

EMBI : 0.0500 (+11.11%)
Emerald Bioscience Announces Notice of Allowance from United States Patent Office for Proprietary Analog of Cannabidiol

Emerald Bioscience, Inc. (OTCQB: EMBI) ("EMBI"), focused on the development of cannabinoid-based therapeutics to address global medical indications, especially those of unmet medical need, today announced...

EMBI : 0.0500 (+11.11%)
Emerald Bioscience to Present at the 9th Annual Glaucoma 360 New Horizons Forum and BIO CEO & Investor Forum

via NEWMEDIAWIRE -- Emerald Bioscience, Inc. (OTCQB: EMBI), focused on the development of cannabinoid-based therapeutics to address global medical indications, especially those of unmet medical need, today...

EMBI : 0.0500 (+11.11%)
Emerald Bioscience Provides Update on Recent Progress and Expected 2020 Milestones

via NEWMEDIAWIRE - Emerald Bioscience, Inc. (OTCQB: EMBI), focused on the development of cannabinoid-based therapeutics to address global medical indications, especially those of unmet medical need, provides...

EMBI : 0.0500 (+11.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade EMBI with:

Key Turning Points

2nd Resistance Point 0.0598
1st Resistance Point 0.0549
Last Price 0.0500
1st Support Level 0.0442
2nd Support Level 0.0384

See More

52-Week High 0.4900
Fibonacci 61.8% 0.3185
Fibonacci 50% 0.2655
Fibonacci 38.2% 0.2125
Last Price 0.0500
52-Week Low 0.0410

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar